BioTek reMEDys Adds UPLIZNA to its Specialty Therapeutics Portfolio

BioTek reMEDys announced the addition of UPLIZNA to its specialty therapeutics portfolio to provide treatment to a broader patient population and further expand upon its diverse pharmaceutical product offering

Sutter Health Plus Changing PBM to CVS Caremark from Express Scripts

Sutter Health Plus is changing its PBM to CVS Caremark® from Express Scripts®. CVS Caremark will manage the pharmacy benefits for its approximately 100,000 members

BioCare Looks to Strengthen Specialty Distribution Business After The Vistria Group Acquisition

The Vistria Group, LP (Vistria) recently announced the acquisition of BioCare, Inc. (BioCare), a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy and logistics services

Providence Group Acquires Skilled Nursing Facility Operator Plum Healthcare Group

Providence Group has acquired California’s second-largest skilled nursing facility operator as the company expands its presence out west

RxLightning and Oncospark Partner Simplifying Oncology Medication Enrollment and Prior Authorization

RxLightning and Oncospark partner to create a platform that streamlines the specialty medication enrollment and prior authorization process for oncology patients

What Will CVS Health Do With Omnicare?

CVS Health operating income decreased 5.8% primarily due to a $431 million goodwill impairment charge associated with the long-term care business in the three months ended September 30, 2021

PCA Pharmacy Will Become Synchrony Pharmacy in 2022

PCA Pharmacy provides customer focused, innovative pharmacy services at skilled nursing, assisted living, and other healthcare facilities in Kentucky, Indiana, Ohio, Michigan, Pennsylvania, Tennessee, Virginia, North Carolina, South Carolina, Florida, Mississippi, Iowa and Florida

Aetna Launches New Network to Cover New Gene Therapies for Rare Diseases

Aetna recently announced an initiative to launch a designated network to cover new gene therapies for rare diseases. This follows an initiative by CVS Health in 2019 to provide self-insured employers with a stop-loss program with Aetna health plans and cover gene therapies